(Q45958574)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19545630%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

title

Intranasal administration of proteoliposome-derived cochleates from Vibrio cholerae O1 induce mucosal and systemic immune responses in mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19545630%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

main subject

Vibrio cholerae

0 references

systemic immune response

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19545630%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Reinaldo Acevedo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19545630%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Adriana Callicó

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19545630%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Judith del Campo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19545630%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Elizabeth González

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19545630%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Bárbara Cedré

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19545630%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Lissette González

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19545630%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Caridad Zayas

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19545630%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Miriam Lastre

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19545630%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Sonsire Fernández

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19545630%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Reynaldo Oliva

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19545630%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Luis García

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19545630%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

José Luis Pérez

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19545630%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Oliver Pérez

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19545630%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

publication date

21 June 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19545630%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19545630%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19545630%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19545630%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

309-315

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19545630%20AND%20SRC:MED&resulttype=core&format=json

Targeting immune response induction with cochleate and liposome-based vaccines

1 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.027

New vaccines require potent adjuvants like AFPL1 and AFCo1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.027

Immunological evaluation of bacterial derived Cochleate and proteoliposome as mucosal adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.027

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.027

Live oral cholera vaccine : from principle to product

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.027

Safety and immunogenicity of the oral, whole cell/recombinant B subunit cholera vaccine in North American volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.027

Protective efficacy of oral whole-cell/recombinant-B-subunit cholera vaccine in Peruvian military recruits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.027

Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.027

Biosafety aspects of the recombinant live oral Vibrio cholerae vaccine strain CVD 103-HgR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.027

A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.027

Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.027

The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.027

Formulation in tablets of a cholera whole cells inactivated vaccine candidate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.027

What about cholera vaccines?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.027

Lipopolysaccharides of Vibrio cholerae: III. Biological functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.027

Preparation and evaluation of vibrio cholerae O1 EL Tor Ogawa lipopolysaccharide-tetanus toxoid conjugates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.027

Cholera vaccine candidate 638: intranasal immunogenicity and expression of a foreign antigen from the pulmonary pathogen Coccidioides immitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.027

Strategy for determination of an efficient Cochleate particle size

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.027

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.027

Production and characterization of a monoclonal antibody against mannose-sensitive hemagglutinin of Vibrio cholerae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.027

Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.027

Proteoliposome derived cochleate as novel adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.027

Scale up of proteoliposome derived Cochleate production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.027

A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.027

Differential induction of the toll-like receptor 4-MyD88-dependent and -independent signaling pathways by endotoxins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.027

Safety and immunogenicity of a proteosome-Shigella flexneri 2a lipopolysaccharide vaccine administered intranasally to healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.027

Oral immunization with size-purified microsphere beads as a vehicle selectively induces systemic tolerance and sensitization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.027

Assessment of pulmonary antibodies with induced sputum and bronchoalveolar lavage induced by nasal vaccination against Pseudomonas aeruginosa: a clinical phase I/II study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.027

Delivery systems: a vaccine strategy for overcoming mucosal tolerance?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.027

Regional induction of adhesion molecules and chemokine receptors explains disparate homing of human B cells to systemic and mucosal effector sites: dispersion from tonsils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.027

Induction of secretory immunity and memory at mucosal surfaces

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.027

Synthesis, characterization, and some immunological properties of conjugates composed of the detoxified lipopolysaccharide of Vibrio cholerae O1 serotype Inaba bound to cholera toxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.027

7 January 2021

Construction and characterization of recombinant Vibrio cholerae strains producing inactive cholera toxin analogs.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.027

7 January 2021

Preliminary assessment of the safety and immunogenicity of a new CTXPhi-negative, hemagglutinin/protease-defective El Tor strain as a cholera vaccine candidate.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.027

7 January 2021

Intransal or intragastric immunization with proteosome-Shigella lipopolysaccharide vaccines protects against lethal pneumonia in a murine model of Shigella infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2009.03.027

7 January 2021

10.1016/J.YMETH.2009.03.027

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19545630%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference